CD40L Priming of Platelets via NF‐κB Activation is CD40‐ and TAK1‐Dependent
Background CD40 ligand (CD40L) is a thromboinflammatory molecule that predicts cardiovascular events. CD40L is a strong activator of nuclear factor kappa B (NF‐κB) in platelets that primes and enhances platelet activation in response to thrombotic stimuli. In addition to its classical receptor CD40,...
Main Authors: | Kevin Kojok, Souhad El Akoum, Mira Mohsen, Walid Mourad, Yahye Merhi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.118.009636 |
Similar Items
-
CD40–CD40L in Neurological Disease
by: Heather D. Ots, et al.
Published: (2022-04-01) -
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse
by: Yizhi Chen, et al.
Published: (2023-06-01) -
CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
by: Steffen Daub, et al.
Published: (2020-11-01) -
CD40/CD40L expression and its prognostic value in cervical cancer
by: G.A. Grazia, et al.
Published: (2023-11-01) -
Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
by: Kundan Solanki, et al.
Published: (2023-01-01)